Julie VanOrsdel Daves

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julie VanOrsdel Daves:

Company Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. SVP Clinical Development Oper. Stock Option (right to buy) 54,000 01 Jun 2023 Direct
DiaMedica Therapeutics Inc. SVP Clinical Development Oper. Voting Common Shares, no par value per share 0 $2.80 01 Jun 2023 Direct

Insider Reports Filed by Julie VanOrsdel Daves

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DMAC DiaMedica Therapeutics Inc. 01 Jun 2023 1 $0 4 SVP Clinical Development Oper. 02 Jun 2023, 17:16
DMAC DiaMedica Therapeutics Inc. 13 Sep 2022 1 $0 4 SVP Clinical Development Oper. 15 Sep 2022, 16:41
DMAC DiaMedica Therapeutics Inc. 13 Sep 2022 0 $0 3 SVP Clinical Development Oper. 15 Sep 2022, 16:15